首页> 外文学位 >Biocompatibility analysis and biomedical device development using novel L-tyrosine based polymers.
【24h】

Biocompatibility analysis and biomedical device development using novel L-tyrosine based polymers.

机译:使用新型基于L-酪氨酸的聚合物的生物相容性分析和生物医学设备开发。

获取原文
获取原文并翻译 | 示例

摘要

L-tyrosine based 'pseudo' poly (amino acids) such as polyphosphates and polyurethanes have been developed using desaminotyrosine tyrosyl hexyl ester (DTH) as the monomer, and characterized with the aim of using them for biomedical applications. The successful establishment of the biocompatibility of these novel materials is critical for their success and acceptance in the biomedical device field. One of the main aims of the research presented in this dissertation has been to evaluate the biocompatibility of novel L-tyrosine based polymers and their degradation products by examining their cytotoxicity, investigating the adhesion and proliferation of human fibroblast cells on L-tyrosine based polymeric substrates, and correlating the cell adhesion to surface wettability and composition of the substrates.;Characterization results of L-tyrosine based polyurethanes and polyphosphate have shown that although these polymers are synthesized using a common monomer, they exhibit dramatically different physico-mechanical properties. Another aim of this dissertation has been to examine the blending of polyphosphate and polyurethanes in order to develop materials with a wider spectrum of physico-mechanical properties and thus obtain a stepwise transition in the material properties by adjusting the blends composition. The blends have been extensively characterized for different bioengineering properties including surface and bulk characteristics. In addition, the possibility of application of polyphosphate and polyurethanes for the formulation of controlled drug delivery devices has been investigated. Drug delivery devices in the form of microparticles and electrospun micro- and nano-fibrous membranes have been developed and certain process parameters associated with the formulation process have been optimized.;The results indicate that L-tyrosine based polymers and their degradation products are non-cytotoxic under test conditions (dosages and time frames examined). The adhesion of cells onto L-tyrosine based polymeric substrates has been found to be a function of the polymer chemistry and its surface wettability. Polymers with moderate hydrophobicity have been found to promote cellular adhesion whereas hydrophilic surfaces retarded cellular adhesion and proliferation. These results coupled with the physico-chemical and mechanical properties of these novel polymers suggest that they are prospective candidates for biomedical applications including tissue engineering and drug delivery devices. Further, results obtained from blend characterizations indicate that the material properties of blends are a strong function of the blend composition and blending of polyphosphate and polyurethanes provides an easy way to obtain materials with a wide range of properties intermediate to the parent polymer properties. Finally, the successful development of drug delivery devices in the form of microparticles and micro- and nano-fibrous membranes has shown that these novel materials can indeed prove to be a very valuable addition to the existing arsenal of biomaterials.
机译:基于L-酪氨酸的“伪”聚氨基酸(如聚磷酸盐和聚氨酯)已使用脱氨基酪氨酸酪氨酰己酯(DTH)作为单体进行了开发,并旨在将其用于生物医学应用。这些新型材料的生物相容性的成功建立对于它们在生物医学设备领域的成功和接受至关重要。本文研究的主要目的之一是通过检查新型基于L-酪氨酸的聚合物及其降解产物的细胞毒性,研究人类成纤维细胞在基于L-酪氨酸的聚合物基质上的粘附和增殖来评估其生物相容性。 L-酪氨酸基聚氨酯和聚磷酸酯的表征结果表明,尽管这些聚合物是使用普通单体合成的,但它们表现出截然不同的物理机械性能。本论文的另一个目的是研究多磷酸盐和聚氨酯的共混物,以开发具有更宽范围的物理机械性能的材料,从而通过调节共混物的组成获得材料性能的逐步过渡。共混物已经针对不同的生物工程特性进行了广泛表征,包括表面和体积特性。另外,已经研究了将聚磷酸盐和聚氨酯用于控制药物递送装置的配方的可能性。已经开发了以微粒和静电纺微纤维和纳米纤维膜形式的药物递送装置,并且优化了与制剂过程相关的某些过程参数。结果表明,基于L-酪氨酸的聚合物及其降解产物不是在测试条件下(检查剂量和时间范围)具有细胞毒性。已经发现细胞对基于L-酪氨酸的聚合物基质的粘附是聚合物化学及其表面润湿性的函数。已经发现具有中等疏水性的聚合物可促进细胞粘附,而亲水性表面则可抑制细胞粘附和增殖。这些结果以及这些新型聚合物的物理化学和机械性能表明,它们是生物医学应用(包括组织工程和药物输送装置)的潜在候选者。此外,从共混物表征获得的结果表明,共混物的材料性能是共混物组合物的强大功能,并且聚磷酸盐和聚氨酯的共混提供了获得具有在母体聚合物性能中间的宽范围性能的材料的简便方法。最后,以微粒,微纤维和纳米纤维膜形式的药物输送装置的成功开发表明,这些新型材料确实可以证明是对现有生物材料库的非常有价值的补充。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号